Takashi Hosokawa
Department Of Otorhinolaryngology Head And Neck Surgery
Osaka, Japan
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Relationship between pedestrian detection specifications of parking sensor and potential safety benefits.
Journal: Accident; analysis and prevention
Published: June 18, 2020
SEMA4A promotes eosinophil survival and contributes to eosinophil-mediated allergic diseases.
Journal: Allergology international : official journal of the Japanese Society of Allergology
Published: July 11, 2018
Lysosomal Protein Lamtor1 Controls Innate Immune Responses via Nuclear Translocation of Transcription Factor EB.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: September 07, 2017
Erratum: Polarization of M2 macrophages requires Lamtor1 that integrates cytokine and amino-acid signals.
Journal: Nature communications
Published: February 28, 2017
Lamtor1 Is Critically Required for CD4+ T Cell Proliferation and Regulatory T Cell Suppressive Function.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: January 31, 2017
Semaphorin 4D inhibits neutrophil activation and is involved in the pathogenesis of neutrophil-mediated autoimmune vasculitis.
Journal: Annals of the rheumatic diseases
Published: October 21, 2016
LRRK1 is critical in the regulation of B-cell responses and CARMA1-dependent NF-κB activation.
Journal: Scientific reports
Published: February 11, 2016
Polarization of M2 macrophages requires Lamtor1 that integrates cytokine and amino-acid signals.
Journal: Nature communications
Published: January 12, 2016
mTOR Complex Signaling through the SEMA4A-Plexin B2 Axis Is Required for Optimal Activation and Differentiation of CD8+ T Cells.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: December 05, 2014
Semaphorin 4D Contributes to Rheumatoid Arthritis by Inducing Inflammatory Cytokine Production: Pathogenic and Therapeutic Implications.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: September 22, 2014
Improvement of health status evaluated by Arthritis Impact Measurement Scale 2 (AIMS-2) and Short Form-36 (SF-36) in patients with rheumatoid arthritis treated with tocilizumab.
Journal: Modern rheumatology
Published: January 10, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026